Advance Auto Parts’ stock rockets as tariffs didn’t change the...
On Thursday, the company said it’ll handle the extra costs tied to the current tariff regime and still deliver its full-year earnings targets. Source link
On Thursday, the company said it’ll handle the extra costs tied to the current tariff regime and still deliver its full-year earnings targets. Source link
Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments. Source link
Last week, the company reported results that missed expectations and withdrew its full-year outlook. Source link
Health and wellness company Hims & Hers, which sells alternatives to weight-loss drugs like Wegovy, is now collaborating with the maker of Wegovy. Source link
CTA Content